Stockreport

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM'24 [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF innovative treatments for cancer patients, today announced that its abstract titled “Evaluation of Anti-uPAR Antibody as a Radiopharmaceutical for Imaging and Treatment [Read more]